Evidence map›Paper›PMID 26909749›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2016

MicroRNA-338 and microRNA-21 co-transfection for the treatment of rat sciatic nerve injury.

Jianyong Wang, Aikeremujiang Muheremu, Ming Zhang, Kai Gong, Chuyi Huang, Yuchen Ji, Yujun Wei, Qiang Ao

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jianyong WangInstitute of Clinical Medicine, Affiliated Hospital of Inner Mongolia University for Nationalities, No 92, Huolinhe Rd, Tongliao, 028000, Inner Mongolia, China.
Aikeremujiang MuheremuMedical Center, Tsinghua University, Beijing, 100084, China.
Ming ZhangInstitute of Clinical Medicine, Affiliated Hospital of Inner Mongolia University for Nationalities, No 92, Huolinhe Rd, Tongliao, 028000, Inner Mongolia, China.
Kai GongMedical Center, Tsinghua University, Beijing, 100084, China.
Chuyi HuangMedical Center, Tsinghua University, Beijing, 100084, China.
Yuchen JiMedical Center, Tsinghua University, Beijing, 100084, China.
Yujun WeiInstitute of Tissue Engineering, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, Liaoning, China.
Qiang AoInstitute of Tissue Engineering, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, Liaoning, China. aoqiang@tsinghua.edu.cn.
Tsinghua University · CNChina Medical University · CNInner Mongolia University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to find if co-transfecting microRNA-338 and microRNA-21 into the neurons in the spinal cord can promote functional recovery after peripheral nerve injury in rats. Animals were divided into three groups: 20 animals in the GFP control vector group (group A), 20 animals in the GFP experimental vector group (group B) and ten animals in the normal control group. Right sciatic nerves of animals in groups A and B were transected and were bridged with collagen nerve conduits with 10 mm distance between the stumps. 3 µl GFP control vector or 3 µl lentiviral vectors encoding the sequence of microRNA-338 and microRNA-21 were injected in the conduit. 8 weeks after the surgery, the treatment effect was evaluated by functional analysis, electrophysiological analysis, immunohistochemical analysis as well as transmitting electronic microscope observations in all the rats. Animals treated with microRNA-338 and microRNA-21 showed significantly better recovery than GFP control group animals by means of functional analysis (Sciatic nerve index -47.7 ± 2.5 vs -59.4 ± 3.7), electrophysiological analysis (Conduction velocity 20.5 ± 2.8 vs 10.5 ± 1.4 m/s), ratio of wet weight of the gastrocnemius muscles (0.83 ± 0.03 vs 0.55 ± 0.06), axon diameter (5.0 ± 1.8 µm vs 4.0 ± 2.2), myelin sheath thickness (1.4 ± 0.43 vs 0.80 ± 0.31 µm) and G-ratio (0.80 ± 0.06 vs 0.75 ± 0.04). Lentiviral vectors encoding microRNA 338 and 21 might be explored in the future as potential therapeutic intervention to promote nerve regeneration.

Indexed as

TransfectionAcetylcholinesteraseAnimalsAxonsDisease Models, AnimalEvoked PotentialsFollow-Up StudiesMaleMicroRNAsMicroscopy, Electron, TransmissionMuscle, SkeletalNeurofilament ProteinsOrgan SizeRatsRats, Sprague-DawleyRecovery of FunctionAcetylcholinesteraseMicroRNAsmirn21 microRNA, ratMIRN338 microRNA, ratneurofilament protein HNeurofilament ProteinsMicroRNA-338, microRNA-21Nerve conduitNerve injuryPeripheralSciatic nerve

Identifiers

PMID26909749
OpenAlexW2285754008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.